Literature DB >> 7562856

Remission of recurrent mature teratoma with interferon therapy.

D Ornadel1, A Wilson, C Trask, J Ledermann.   

Abstract

Although alpha-interferons have anti-tumour activity in a variety of solid and haematological malignancies, they are not generally considered to be effective therapy for mature testicular teratomas. We report a case of complete remission in a patient with recurrent mature teratoma following treatment with alpha-interferon.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7562856      PMCID： PMC1295339     

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   5.344


  8 in total

Review 1.  Interferons.

Authors:  F R Balkwill
Journal:  Lancet       Date:  1989-05-13       Impact factor: 79.321

Review 2.  Biological response modifiers: the new immunotherapy.

Authors:  K A Foon
Journal:  Cancer Res       Date:  1989-04-01       Impact factor: 12.701

3.  Ten-year survival and late sequelae in testicular cancer patients treated with cisplatin, vinblastine, and bleomycin.

Authors:  G Stoter; A Koopman; C P Vendrik; A Struyvenberg; D T Sleyfer; P H Willemse; H Schraffordt Koops; A T van Oosterom; W W ten Bokkel Huinink; H M Pinedo
Journal:  J Clin Oncol       Date:  1989-08       Impact factor: 44.544

4.  The development of non-germ cell malignancies within germ cell tumors. A clinicopathologic study of 11 cases.

Authors:  T M Ulbright; P J Loehrer; L M Roth; L H Einhorn; S D Williams; S A Clark
Journal:  Cancer       Date:  1984-11-01       Impact factor: 6.860

5.  Late recurrences in long-term survivors of germ cell neoplasms.

Authors:  M J DeLeo; F A Greco; J D Hainsworth; D H Johnson
Journal:  Cancer       Date:  1988-09-01       Impact factor: 6.860

6.  Sarcoma arising in a residual testicular teratoma after cytoreductive chemotherapy.

Authors:  A D Ahlgren; C R Simrell; T J Triche; R Ozols; S H Barsky
Journal:  Cancer       Date:  1984-11-01       Impact factor: 6.860

7.  Response of differentiated but not anaplastic teratoma to interferon.

Authors:  G J Rustin; S B Kaye; C J Williams; E S Newlands; K D Bagshawe; J L Toy
Journal:  Br J Cancer       Date:  1984-11       Impact factor: 7.640

8.  Post-chemotherapy surgery in advanced non-seminomatous germ-cell testicular tumours: the significance of histology with particular reference to differentiated (mature) teratoma.

Authors:  D Tait; M J Peckham; W F Hendry; P Goldstraw
Journal:  Br J Cancer       Date:  1984-11       Impact factor: 7.640
  8 in total
  2 in total

1.  Bifocal mixed germ-cell tumor with growing teratoma syndrome and metachronous mature metastases: case report.

Authors:  Johann Peltier; Matthieu Vinchon; Marc Baroncini; Olivier Kerdraon; Patrick Dhellemmes
Journal:  J Neurooncol       Date:  2008-06-24       Impact factor: 4.130

2.  Ovarian germ cell tumors with rhabdomyosarcomatous components and later development of growing teratoma syndrome: a case report.

Authors:  Usama Al-Jumaily; Maysa Al-Hussaini; Fatenah Ajlouni; Abdulrahman Abulruz; Iyad Sultan
Journal:  J Med Case Rep       Date:  2012-01-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.